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Abstract
Objective Studies in children with heart disease have been
hampered by a lack of easily identifiable patient groups.
Currently, there are few prospective population-based reg-
istries covering the entire spectrum of heart disease in chil-
dren. KinCor is a Dutch national registry for children with
heart diseases. This paper presents the aims, design and
interim results of the KinCor project.
Methods All children presenting at a Dutch university med-
ical centre with a diagnosis of heart disease from 2012 on-
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wards were eligible for registration in the KinCor database.
Data entry is through a web-based portal. Entry codes have
been synchronised with the European Paediatric Cardiac
Coding system, allowing coupling with similar databases
for adults, such as CONCOR.
Results Between June 2012 and July 2015, 8421 patients
were registered (76 % of those eligible). Median age of
the patients was 9.8 years, 44.7 % were female; 6782 pa-
tients had morphological congenital heart disease. The most
prevalent morphological congenital heart defects were ven-
tricular septal defects (18 %), Tetralogy of Fallot (10 %)
and transposition of great arteries (9 %). For 42 % of the
patients additional diagnoses were registered. Sixty percent
of patients had undergone at least one intervention (catheter
intervention or surgery).
Conclusion The KinCor database has developed into a large
registry of data of children with all types of heart disease
and continues to grow. This database will provide the op-
portunity for epidemiological research projects on congeni-
tal and other types of heart disease in children. Entry codes
are shared with the CONCOR database, which may provide
a unique dataset.
Keywords Registry · Database · Child · Paediatric ·
Congenital · Heart disease
Introduction
Congenital heart diseases (CHD) are a substantial burden
on global health [1] and have major impact on patients’
survival and quality of life [2]. Expressed in disability-
adjusted life years, the impact of CHD ranks among the
highest of all diseases [3].
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Estimates of birth prevalence of CHD vary between
countries and through time periods and have ranged from
2.5 to 5.5 per 1000 live births [4, 5]. Information on
population-based prevalence rates of CHD in the paediatric
age range is scarce and has been shown to range from 6.3
to 13.1 per 1000 children aged 0 to 18 years [6–8]. More
up-to-date population-based information on prevalence of
heart disease in children is required. Furthermore, there
is a strong need for data on outcome and on the clinical
state of children with heart disease. Ideally, this should
cover the entire age range of this patient population, a wide
spectrum of heart anomalies and a high level of inclusion.
Population-based registries of patients with heart disease
can provide the infrastructure for extensive epidemiological
research in this field. In the Netherlands, there is a national
registry for adult patients with CHD, CONCOR [9]. How-
ever, a national registry for paediatric patients with heart
disease has been lacking. KinCor, a Dutch national registry
for paediatric patients with heart diseases, was launched
in 2012. In this paper, we aim to provide information
on the opportunities offered by this project and present
interim results, particularly the distribution of the various
diagnoses in the database after three years of inclusion.
Methods
Organisation
The KinCor project was initiated by the departments of pae-
diatric cardiology of the eight university medical centres in
the Netherlands (see author affiliations), in collaboration
with the Netherlands Heart Foundation and the Dutch Fed-
eration of University Medical Centres.
The general aims of the KinCor project are to facilitate
studies on heart disease in children with regard to:
● epidemiology;
● risk factors for mortality and morbidity;
● larger cohort and intervention studies in specific patient
populations;
● the effects of different treatment strategies.
A steering committee and a project committee manage
the project. The steering committee is responsible for gen-
eral policy and management of the KinCor project, includ-
ing strategic, scientific and legal aspects and implementa-
tion of the registration system in the participating depart-
ments.
The project committee consists of representatives of each
of the involved departments and is responsible for actual
patient inclusion, data collection, coding, data entry, data
management and management of the research nurses.
The research committee consists of paediatric cardiolo-
gists and a representative from one of the other paediatric
subspecialties, patient organisations and a legal counsellor.
This committee is responsible for the evaluation of research
protocols and approval of requests for data.
Ethics and regulations
The KinCor database complies with the national Personal
Data Protection Act and has been reported to the Personal
Data Authority. Legal compliance has been tested and ap-
proved by the contributing centres.
Study population
All children aged 0 to 18 years presenting at the partici-
pating departments with a new or known diagnosis of heart
disease are eligible for inclusion in the KinCor database.
Patients who meet the inclusion criteria are informed about
the KinCor project during an outpatient visit. They are
handed a document with detailed information about Kin-
Cor, along with a consent form that patients and/or their
parents can hand in right away, or later by mail. For addi-
tional information patients are also referred to the website
(www.kincor.nl). It is only after consent is given that rele-
vant information is retrospectively collected based on med-
ical records, and data on diagnosis, interventions and life
status are prospectively collected during follow-up. At each
outpatient visit, data of registered patients are updated by
the data managers by checking for new diagnoses, interven-
tions, diagnostic procedures and complications. Inclusion
and update procedures are evaluated twice a year during
meetings for the data managers.
Excluded from inclusion are patients who:
● were discharged from outpatient follow-up before start
of the registration,
● were transferred to the care of an adult cardiologist be-
fore start of the registration.
Children with heart disease who were exclusively fol-
lowed in non-academic medical centres have not been in-
cluded in the KinCor registration so far, but will be in the
near future.
Parents or legal guardians are asked for consent for inclu-
sion of their child’s data in the registration system. When
the child is 12 years or older, both parents/guardians and
the child are asked for consent, in accordance with Dutch
legislation.
Data coding and entry
Diagnoses, surgical interventions, catheter interventions
and other interventions are coded using the European
630 Neth Heart J (2016) 24:628–639
Paediatric Cardiac Coding (EPCC) system [10]. For the
purpose of the KinCor database, subsets of 76 and 152
codes for diagnoses of heart disease and interventions,
respectively, were selected. In case of multiple diagnoses
in one patient, the defect or disease that is judged by the
attending cardiologist to be predominant is the main diag-
nosis. The other diagnoses are recorded as subdiagnoses. If
a patient has both CHD and acquired heart disease, the con-
genital defect is recorded as the main diagnosis. Individual
participants are labelled with a unique and anonymised
KinCor identifier. For each participant, date of birth, gen-
der, diagnosis and any catheter and/or surgical interventions
are entered into the database. Status (alive, deceased, lost
to follow-up) and date of diagnosis when heart disease was
not diagnosed at birth are also recorded.
Security
Three levels of security are used to ensure safety of the data
in the KinCor database: server security, application security
and database security. The KinCor application and database
are running on servers hosted by a party certified according
to NEN7510, ISO 27001, ISO 9001 and ISO 14001. The
NEN7510 and ISO 27001 are standards for information se-
curity and are obligatory to ensure safe storage of patient-
related data on servers. Along with the security protocols in
place to comply with these information security standards
there are firewall policies set up to restrict access to the
hosting environment containing the data. Within the appli-
cation, several other measures have been taken to ensure the
data’s integrity and safety, such as an SSL encryption layer
to reach the frontend of the application, and application
coding security to prevent the possibilities of ‘SQL injec-
tion’, ‘Cross Site Scripting’, ‘Cross Site Request Forgery’
and ‘Click Jacking’. Furthermore, a two-factor authenti-
cation procedure is used which provides identification of
users by means of a combination of two different compo-
nents. The KinCor application uses a username-password
combination component and a security token that generates
a cryptographic key which is requested upon access of the
application. Also, all database transactions are logged.
All data that can be traced back to the identity of the
patients are stored in the database with an AES encryption.
In case a patient no longer wishes to take part in the Kin-
Cor project, the data are anonymised through a SHA224
cryptographic hashing algorithm.
Quality insurance
At regular intervals a random sample of the data in the
database is checked for its compliance with the source data
(individual electronic patient files in submitting hospitals)
by cross check by members of the project group. In an
initial step we checked the data present for seven congenital
heart diagnoses in three participating centres. Twenty-one
patients were selected per centre. The agreement between
the data in the database and in the source files was excellent.
Requests for data use for research projects
Researchers may submit a request for data from the KinCor
database for specific research projects. For details on this
procedure please see www.kincor.nl.
Data analyses
We have assessed the total number of patients registered
between June 2012 and July 2015. For the purpose of
this article, heart diseases were divided into two categories:
morphological congenital heart diseases, that is, develop-
mental defects resulting in structural malformations, and
other types of hearts diseases, including for example car-
diomyopathies and conduction and rhythm disorders. All
analyses were performed using Statistical Package of Social
Sciences (SPSS) version 22.0 for windows.
Interim results
Between June 2012 and July 2015, 8421 patients were reg-
istered in the KinCor database. This corresponds with 76 %
of eligible patients and with 95 % of all patients who re-
sponded to the request for participation. Median age of
the patients was 9.8 years; 44.6 % were female (Table 1).
Ninety-one percent of patients were alive and in follow-up
at the time of this study. In the last 3 years 68 patients died
(data not shown). In 41 cases, death was directly related to
a previous intervention or diagnostic procedure (26 patients
died within 30 days after that intervention or diagnostic pro-
cedure, and 15 patients died longer than 30 days after that
intervention or diagnostic procedure).
Of the total population of patients, 6782 (80 %) had
a morphological CHD as main diagnosis, and 1639 had
another type of heart disease (20 %).
Fig. 1 shows the distribution of morphological CHD reg-
istered as main diagnosis. Among these, the most prevalent
defects were ventricular septal defects (perimembranous,
muscular, subarterial and VSD not otherwise specified; n =
1197; 18 %), Tetralogy of Fallot (n = 685; 10 %) and trans-
position of great arteries (n = 638; 9 %). Within the cate-
gory other types of heart diseases, supraventricular rhythm
disturbances were by far the most common (29 %; Fig. 2).
One or more subdiagnoses were registered for 3543 pa-
tients (42 %). Fig. 3 shows the percentage of patients with
one or more subdiagnoses, stratified by a selection of main
diagnoses. This percentage was highest in patients with
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Table 1 Characteristics of patients registered between June 2012 and
July 2015 (n = 8421)a
Characteristics Percentage/Median (range)
Age (median and range in years) 9.8 (0.15–20.9)
Age group (%)
0–1 year 2.8
1–4 years 18.3
4–12 years 39.3
12–16 years 22.9
>16 years 16.7
Gender (%)
Female 44.7
Male 55.3
Status (%)
Alive and in follow-up 91
Alive at discharge or transferb 5.1
Died at or after birth 0.2
Unknown status or loss to follow-up 3.7
aValues are percentages in case of categorical variables, or means
(with standard deviation) in case of continuous variables
bAlive at discharge from follow-up or at transfer to adult cardiologist
or general paediatrician
atrioventricular septal defects and coarctation of the aorta
in particular (68 and 69 % respectively).
Sixty percent of patients had undergone at least one in-
tervention, either catheter intervention or heart surgery. The
distribution of interventions, by main diagnosis, is shown
Fig. 1 Distribution of morpho-
logical congenital heart diseases
(n = 6782). VSD ventricular
septal defect, ASD atrial septal
defect, TGA transposition of
great arteries, Coa coarctation of
the aorta, vPS valvular pulmonic
stenosis, ToF Tetralogy of Fal-
lot, vAS valvular aortic stenosis,
AVSD atrioventricular septal de-
fect, PDA persistent ductus arte-
riosus, Bicusp Ao bicuspid aortic
valve, HLHS Hypoplastic Left
Heart Syndrome, NOS not other-
wise specified, L-R shunt left to
right shunt
in Fig. 4. Patients with transposition of the great arteries,
Tetralogy of Fallot, coarctation of the aorta and atrioven-
tricular septal defects had the highest percentage of surgical
interventions. Patients with valvular aortic stenosis, trans-
position of the great arteries and valvular pulmonary steno-
sis had the highest percentage of catheter interventions.
Discussion
The KinCor registry has successfully included over 8000
patients so far, and inclusion continues.
Congenital heart disease databases may be important
tools for research. However, only few have been available
so far. In Denmark [11] and Germany [12] large national
registries for CHD are operating that have provided data
on, for instance, the risk for psychiatric disorders in CHD
patients [13] and on the epidemiology of CHD in Germany
[12, 14, 15]. Currently, Eurocat is the largest European Net-
work of population-based registries for congenital anoma-
lies [16–18]. The network consists of 43 registries from
23 European countries. The Netherlands is a member of
this European network, but inclusion is limited to the three
Northern provinces, representing 10 % of all births in the
Netherlands.
Cardiac surgery databases, such as the Congenital Heart
Surgery Database of the Society of Thoracic Surgeons
[19, 20] and the European Association for Cardio-Tho-
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Fig. 2 Distribution of other
types of heart diseases (n =
1639) dCMP dilated cardiomy-
opathy, hCMP hypertrophic
cardiomyopathy, rCMP restric-
tive cardiomyopathy, NOS not
otherwise specified
Fig. 3 Percentage of patients
with one or more subdiag-
noses, by main diagnosis. Bis-
cusp Ao bicuspid aortic valve,
PDA persistent ductus arte-
riosus, AVSD atrioventricular
septal defect, vAS valvular aor-
tic stenosis, ToF Tetralogy of
Fallot, vPS valvular pulmonic
stenosis, Coa coarction of the
aorta, TGA transposition of great
arteries, ASD atrial septal defect,
VSD ventricular septal defect
Neth Heart J (2016) 24:628–639 637
Fig. 4 Prevalence of inter-
ventions, by main diagnosis.
Biscusp Ao bicuspid aortic
valve, PDA persistent ductus
arteriosus, AVSD atrioventricu-
lar septal defect, vAS valvular
aortic stenosis, ToF Tetralogy of
Fallot, vPS valvular pulmonic
stenosis, Coa coarction of the
aorta, TGA transposition of great
arteries, ASD atrial septal defect,
VSD ventricular septal defect
racic Surgery database [21], include surgery-related data
primarily, excluding parts of the paediatric congenital heart
population. In contrast, KinCor provides insight into the
prevalence, epidemiology and outcome of the full spectrum
of paediatric heart disease, with nationwide coverage.
Ventricular septal defect (VSD) was by far the most
common morphological congenital heart defect in KinCor
(18 %). In contrast, in the Danish Register of Congenital
Heart Disease [11] VSD accounted for only 8 %. Compared
with the KinCor database, patent arterial duct was more
common in the Danish database, accounting for 10.7 % of
all CHD. This difference can be explained by the fact that
the Danish database included premature infants with patent
arterial duct as the only cardiac diagnosis [22]. In the Ger-
man PAN study the proportion of VSD among all CHD
was almost 50 % [12]. This may be due to the fact that
approximately 70 % of patients with mild cardiac defects
were enrolled by non-academic cardiology units. The PAN
study therefore included relatively more mild congenital
heart defects. In contrast, the KinCor project has only in-
cluded patients followed in academic paediatric cardiology
departments. Inclusion will start in non-university hospitals
soon.
The CONCOR registry [9], the Dutch national registry
for adult patients with CHD, has shown results more similar
to ours. This may point towards a bias of inclusion of rel-
atively older children in the initial phase of data inclusion
in KinCor. Among adults with CHD, Tetralogy of Fallot
was the most prevalent main diagnosis (14.1 %) followed by
aortic coarctation (10.4 %). Another difference compared
with the KinCor registry is that the CONCOR registry in-
cludes patients from non-academic hospitals, which may
have influenced inclusion rates of patients.
In the Netherlands, CONCOR has set the stage for the
successful use of registry data to improve knowledge on
CHD in the adult population. The KinCor database was de-
signed to allow close collaboration between these systems.
Since the KinCor database uses internationally acknowl-
edged coding systems for diagnosis and interventions, cou-
pling to other international databases, including for exam-
ple CONCOR, the PAN study or the more recently launched
DANARA project [23] should be possible, within the limits
set by legislation on privacy and databases.
Databases such as KinCor may provide a platform to
identify patients for translational research, e. g. on pre-
dictive value of morphological characteristics on outcome
(such as other researchers have shown for bicuspid aortic
valves [24]), on mechanisms of inheritance or biomarkers,
or treatment targets for impending heart failure. In its cur-
rent stage KinCor is not related to a biobank, mainly for
practical reasons. Coupling of KinCor data to existing or
new biobanks is an opportunity for the future.
There are some limitations to consider when evaluating
the KinCor registry. Firstly, the response rate is currently
estimated to be 76 % of eligible. Non-response is a com-
mon and an inevitable part of population registries. At
present, however, there is no reason to assume underrepre-
sentation of certain diagnoses or age categories because of
non-response.
Secondly, patients with complex congenital heart defects
are currently labelled according to the main diagnosis. The
consequence is that there may be some heterogeneity within
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each subgroup of patients with heart disease with the same
main diagnosis.
In the KinCor database, more boys (55.3 %) than girls
(44.7 %) have been registered. A similar sex distribution
has been found in the CONCOR database (52 % versus
48 %) [9]. One possible explanation of the male domi-
nance in our patient population may be a higher prevalence
of complex congenital heart defects in boys, as previously
suggested by data from the United Kingdom [25]. This
requires further research.
A small percentage of the patients in the database at
present is older than 18 years of age. These are patients
that had not yet turned 18 at the start of inclusion in 2012.
Retrieval of details of their history and follow-up may not
be facilitated by KinCor, since there may no longer be a di-
rect relationship between participating physicians and these
adult patients. This may be solved by coupling of KinCor
and CONCOR data in the future. At present KinCor, like
many other databases in the field, depends on external and
temporary funding.
Conclusion
Currently, the KinCor database contains data of a consider-
able number of children with heart disease and data of other
patients continue to be collected. The KinCor database will
provide a unique opportunity for epidemiological research
on congenital and other types of heart defects in children
in the Netherlands.
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